CVS Health Corp. (CVS)
Stock Price Chart
Stock Quote
| Trading Day | Feb 24, 2020 |
| Last Price | $67.92 |
| Change ($) | -3.59 |
| Change (%) | -5.02% |
| Previous Close | 71.51 |
| Day's Open | 69.43 (-2.91%) |
| Day's Range | 67.72 - 69.94 |
| Day's Volume | 9,627,633 |
| 52-Week Range | 51.72 - 76.44 |
Key Info
| Market Cap | 93.26B |
| Revenue (ttm) | 255.77B |
| Net Income (ttm) | 6.63B |
| Shares Out | 1.30B |
| EPS (ttm) | 5.08 |
| PE Ratio | 14.08 |
| Forward PE | 9.42 |
| Dividend | $2.00 |
| Dividend Yield | 2.94% |
Key Stats and Metrics
| Market Cap | 93.26B |
| Enterprise Value | 156.89B |
| Earnings Date (est) | May 1, 2020 |
| Ex-Dividend Date | Jan 22, 2020 |
| Shares Outstanding | 1.30B |
| Float | 1.30B |
| EPS (basic) | 5.1 |
| EPS (diluted) | 5.08 |
| FCF / Share | 7.99 |
| Dividend | $2.00 |
| Dividend Yield | 2.94% |
| Earnings Yield | 7.48% |
| FCF Yield | 11.14% |
| Payout Ratio | 39.20% |
| Shares Short | 18.68M |
| Short Ratio | 2.84 |
| Short % of Float | 1.44% |
| Beta | 0.90 |
| PE Ratio | 14.08 |
| Forward PE | 9.42 |
| P/FCF Ratio | 8.98 |
| PS Ratio | 0.36 |
| PB Ratio | 1.46 |
| Revenue | 255.77B |
| Operating Income | 11.99B |
| Net Income | 6.63B |
| Free Cash Flow | 10.39B |
| Net Cash | -63.63B |
| Net Cash / Share | -46.34 |
| Gross Margin | 17.41% |
| Operating Margin | 4.69% |
| Profit Margin | 2.60% |
| FCF Margin | 4.06% |
| ROA | 3.53% |
| ROE | 10.81% |
| ROIC | 8.50% |
Stock Analysis Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 256,776 | 194,579 | 184,786 | 177,546 | 153,290 | 139,367 | 126,761 | 123,120 | 107,080 | 95,778 |
| Revenue Growth | 31.96% | 5.3% | 4.08% | 15.82% | 9.99% | 9.94% | 2.96% | 14.98% | 11.8% | - |
| Gross Profit | 45,528 | 31,538 | 28,528 | 28,834 | 26,528 | 25,367 | 23,783 | 22,488 | 20,562 | 20,219 |
| Operating Income | 11,987 | 4,021 | 9,538 | 10,386 | 9,454 | 8,799 | 8,037 | 7,210 | 6,331 | 6,137 |
| Net Income | 6,634 | -594 | 6,622 | 5,317 | 5,237 | 4,644 | 4,592 | 3,864 | 3,462 | 3,427 |
| Shares Outstanding | 1,301 | 1,044 | 1,020 | 1,073 | 1,118 | 1,161 | 1,217 | 1,271 | 1,338 | 1,367 |
| Earnings Per Share | 5.08 | -0.57 | 6.44 | 4.90 | 4.63 | 3.96 | 3.74 | 3.01 | 2.57 | 2.49 |
| EPS Growth | - | - | 31.43% | 5.83% | 16.92% | 5.88% | 24.25% | 17.12% | 3.21% | - |
| Dividend Per Share | 2.00 | 2.00 | 2.00 | 1.70 | 1.40 | 1.10 | 0.90 | 0.65 | 0.50 | 0.35 |
| Dividend Growth | 0% | 0% | 17.65% | 21.43% | 27.27% | 22.22% | 38.46% | 30% | 42.86% | - |
| Operating Cash Flow | 12,848 | 8,865 | 8,007 | 10,141 | 8,539 | 8,137 | 5,783 | 6,671 | 5,856 | 4,779 |
| Capital Expenditures | -2,457 | -2,037 | -1,918 | -2,224 | -2,332 | -2,125 | -1,930 | -2,007 | -1,868 | -1,971 |
| Free Cash Flow | 10,391 | 6,828 | 6,089 | 7,917 | 6,207 | 6,012 | 3,853 | 4,664 | 3,988 | 2,808 |
| Cash & Equivalents | 25,370 | 22,313 | 1,919 | 3,458 | 2,547 | 2,515 | 4,177 | 1,380 | 1,418 | 1,431 |
| Total Debt | 89,002 | 73,429 | 27,002 | 27,531 | 27,464 | 12,890 | 13,402 | 9,828 | 10,014 | 10,057 |
| Net Cash / Debt | -63,632 | -51,116 | -25,083 | -24,073 | -24,917 | -10,375 | -9,225 | -8,448 | -8,596 | -8,626 |
| Assets | 222,449 | 196,456 | 95,131 | 94,462 | 92,437 | 74,187 | 71,526 | 66,221 | 64,543 | 62,169 |
| Liabilities | 158,279 | 137,913 | 57,436 | 57,628 | 55,234 | 36,224 | 33,588 | 28,568 | 26,492 | 24,469 |
| Book Value | 63,864 | 58,225 | 37,691 | 36,830 | 37,196 | 37,958 | 37,938 | 37,653 | 38,051 | 37,700 |
Company Profile
Company Details
| Full Name | CVS Health Corp. |
| Home Country | United States |
| Employees | 290,000 |
| CEO | Larry J. Merlo |
Stock Information
| Ticker symbol | CVS |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Healthcare Plans |
Description
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. The company's Retail/LTC segment sells prescription drugs and general merchandise, such as over-the-counter drugs, beauty products, cosmetics, and personal care products, as well as provides health care services through its MinuteClinic walk-in medical clinics. Its Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management, Medicare plans, PDPs, Medicaid health care management services, workers' compensation administrative services, and health information technology products and services. The company's customers include employers, insurance companies, unions, government employee groups, health plans, Medicare Part D prescription drug plans, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans, individuals, college students, workers, labor groups, and expatriates. As of December 31, 2018, it had approximately 40 leased on-site pharmacies, 25 leased retail specialty pharmacy stores, 20 specialty mail order pharmacies, and 90 branches for infusion and enteral services; and 9,900 retail locations and 1,100 MinuteClinic locations, as well as operated an online retail pharmacy Websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.